Cargando…

Expression of CREPT is associated with poor prognosis of patients with renal cell carcinoma

Cell-cycle-associated and expression-elevated protein in tumor (CREPT) functions as a cell cycle modulator that enhances the transcription of cyclin D1 by interacting with RNA polymerase II. CREPT has been identified to be overexpressed in various human cancer types; however, the expression and sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Huaqi, Cao, Qingfei, Zhao, Haiyue, Wang, Shenheng, Chen, Weinan, Zhang, Xiaowei, Chang, Zhijie, Xu, Tao, Ye, Xiongjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781659/ https://www.ncbi.nlm.nih.gov/pubmed/31611989 http://dx.doi.org/10.3892/ol.2019.10831

Ejemplares similares

CREPT is required for murine stem cell maintenance during intestinal regeneration
por: Yang, Liu, et al.
Publicado: (2021)

CREPT Disarms the Inhibitory Activity of HDAC1 on Oncogene Expression to Promote Tumorigenesis
por: Cao, Yajun, et al.
Publicado: (2022)

Overexpression of CREPT confers colorectal cancer sensitivity to fluorouracil
por: Kuang, Yan-Shen, et al.
Publicado: (2018)

CREPT/RPRD1B promotes tumorigenesis through STAT3-driven gene transcription in a p300-dependent manner
por: Zhai, Wanli, et al.
Publicado: (2021)

Expression and Clinical Significance of CREPT and CDK4 in Cervical Cancer
por: YAO, Shenghui, et al.
Publicado: (2021)

Purification and Analysis of the CREPT Antibody from Mouse Ascites
por: Xie, Zhihao, et al.
Publicado: (2022)

A cell-permeable peptide-based PROTAC against the oncoprotein CREPT proficiently inhibits pancreatic cancer
por: Ma, Danhui, et al.
Publicado: (2020)

Overexpression of cell-cycle related and expression-elevated protein in tumor (CREPT) in malignant cervical cancer
por: Wen, Na, et al.
Publicado: (2020)

Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression
por: Ma, Juntao, et al.
Publicado: (2017)

MicroRNA-300 inhibits the growth of hepatocellular carcinoma cells by downregulating CREPT/Wnt/β-catenin signaling
por: Bai, Jinping, et al.
Publicado: (2019)

CREPT/RPRD1B associates with Aurora B to regulate Cyclin B1 expression for accelerating the G2/M transition in gastric cancer
por: Ding, Lidan, et al.
Publicado: (2018)

CREPT Promotes Melanoma Progression Through Accelerated Proliferation and Enhanced Migration by RhoA-Mediated Actin Filaments and Focal Adhesion Formation
por: Liu, Hui, et al.
Publicado: (2019)

CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation
por: Zhang, Yanquan, et al.
Publicado: (2018)

The Significance of Fibrosis Quantification as a Marker in Assessing Pseudo-Capsule Status and Clear Cell Renal Cell Carcinoma Prognosis
por: Qin, Caipeng, et al.
Publicado: (2020)

IPPC: an interactive platform for prostate cancer multi-omics data integration and analysis
por: Ye, Xiongjun, et al.
Publicado: (2021)

High expression of FUT3 is linked to poor prognosis in clear cell renal cell carcinoma
por: Meng, Li, et al.
Publicado: (2017)

High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma
por: Niu, Haitao, et al.
Publicado: (2018)

High expression of FER tyrosine kinase predicts poor prognosis in clear cell renal cell carcinoma
por: WEI, CAN, et al.
Publicado: (2013)

Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma
por: Su, Hengchuan, et al.
Publicado: (2016)

ZFX is a Strong Predictor of Poor Prognosis in Renal Cell Carcinoma
por: Li, Changying, et al.
Publicado: (2015)

Rab25 expression predicts poor prognosis in clear cell renal cell carcinoma
por: LIU, LUNZHI, et al.
Publicado: (2014)

Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Liu, Xianhui, et al.
Publicado: (2022)

High CENPA expression in papillary renal cell carcinoma tissues is associated with poor prognosis
por: Li, Junwu, et al.
Publicado: (2022)

Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Kurota, Yuta, et al.
Publicado: (2023)

Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma
por: Fu, Hangcheng, et al.
Publicado: (2016)

Management of metastatic renal cell carcinoma in patients with poor prognosis
por: Bullock, Andrea, et al.
Publicado: (2010)

High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma
por: Xu, Yi, et al.
Publicado: (2016)

Lower mean platelet volume predicts poor prognosis in renal cell carcinoma
por: Yun, Zhi-yuan, et al.
Publicado: (2017)

Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2019)

Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma
por: Song, Zhengshuai, et al.
Publicado: (2020)

GLIS2 redundancy causes chemoresistance and poor prognosis of gastric cancer based on co-expression network analysis
por: Yuan, Jingsheng, et al.
Publicado: (2019)

High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma
por: Wu, Jie, et al.
Publicado: (2020)

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma
por: Ronkainen, Hanna, et al.
Publicado: (2011)

Loss of KCNJ15 expression promotes malignant phenotypes and correlates with poor prognosis in renal carcinoma
por: Liu, Yang, et al.
Publicado: (2019)

Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis
por: Fu, Yang, et al.
Publicado: (2019)

Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma
por: Gao, Yuan, et al.
Publicado: (2020)

Low REST Expression Indicates a Biomarker of Poor Prognosis in Patients with Renal Cell Carcinoma
por: Lv, Chaoxiang, et al.
Publicado: (2021)

Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma
por: Zhu, Wenbiao, et al.
Publicado: (2021)

FXYD3 Expression Predicts Poor Prognosis in Renal Cell Carcinoma with Immunosuppressive Tumor Microenvironment
por: Yonekura, Satoru, et al.
Publicado: (2022)

High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma
por: Tang, Yuting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vdqevvrrc54vsrmj34d97f1t82